Focus Stocks
Baxter International near Key Resistance Area
Published on Monday, 13 February 2012 08:12 Written by TradersHuddle Wire
New York, February 13th (TradersHuddle.com) - Shares of Baxter International, Inc. (NYSE:BAX) are trading very close to calculated resistance at $57.15 with the current price action closing at just $56.84 placing the stock near levels that make it difficult to buy.
Baxter International Inc. (NYSE:BAX) develops, manufactures, and markets products and technologies related to hemophilia, immune disorders, infectious diseases, kidney disease, trauma and other chronic medical conditions. The healthcare products are used by hospitals, kidney dialysis centers, nursing homes, rehabilitation centers, doctors' offices, and research laboratories.
Baxter's current stock range is defined by current calculated support defined at $47.55 and by the resistance level at $57.15, the stock is clearly over-extended from support, making it difficult to establishing new long positions at this level.
Traders don't have a clear entry point for Baxter International, as the stock is well above support, however, as the stock pulls back towards $47.55 it will definitely provide a reference point to establish a trade. On the other hand if the stock decides to break above resistance level at $57.15 then traders will get an opportunity to enter Baxter International stock by establishing a position as the stock moves to a higher range.
Related Articles
- The 200 Day Moving Average is Key for Baxter International
- Baxter’s Low Glucose PD Solutions Favorably Impacted Metabolic Measures Including Glycemic Control in Trials of Diabetics Undergoing Dialysis
- Baxter to Present at Goldman Sachs 33rd Annual Global Healthcare Conference
- Baxter Announces ADVATE Approval in China for the Treatment of Hemophilia A
- Baxter International Is Dipping Below Support
- Is Baxter International Close to Support?
- The 200 Day Moving Average is a Great Reference Point for Baxter International
- Is Baxter International Close to Support?
- Baxter Declares Quarterly Dividend
Related Partner Headlines
- 6 Low-Yield Dividend Captures - TheStreet.com
- Baxter Announces ADVATE Approval in China for the Treatment of Hemophilia A - Benzinga
- Baxter International Inc. (BAX): Today's Featured Health Services Loser - TheStreet.com
- 'Mad Money' Lightning Round: Devon's Worth More - TheStreet.com
- 7 Hot Stocks on Traders' Radars - TheStreet.com
- 'Mad Money' Lightning Round: Bullish on Baxter - TheStreet.com
- Baxter International Stock To Go Ex-dividend Tomorrow (BAX) - TheStreet.com
- UPDATE: Dougherty & Company Raises PT on Baxter International to $56 - Benzinga
- Baxter Receives Marketing Authorization in European Union for VEPACEL Pre-Pandemic Influenza Vaccine - Benzinga
- Baxter Initiates Phase III Adult Stem Cell Clinical Trial for Chronic Cardiac Condition - Benzinga
TradersHuddle Search
| Sponsored By: |
|
Stock Search: |
|
Site Search: Loading
|
Latest Partner Headlines
-
The Dow Bounces on Test of 12,312 - TheStreet.com -
Coming Week: Top Nine Earnings on Deck - TheStreet.com -
For Ambitious Students, Entrepreneurship Can Be a Big Win - TheStreet.com -
Something's Not Right in the Video-Game Space - TheStreet.com -
Stock Futures Rise on Eurobond Talk - TheStreet.com -
You Can Let Your Guard Down: Ask Noah - TheStreet.com -
NYSE Is Winning the IPO Listing War - TheStreet.com -
Apple Strengthens Its Supply Chain - TheStreet.com
Stock Market
Dow Jones
Company ID [INDEXDJX:.DJI] Last trade:12,529.75 Trade time:4:05PM EDT Value change:▲33.60 (0.27%)S&P 500
Company ID [INDEXSP:.INX] Last trade:1,320.68 Trade time:4:32PM EDT Value change:▲1.82 (0.14%)NASDAQ
Company ID [INDEXNASDAQ:.IXIC] Last trade:2,839.38 Trade time:5:16PM EDT Value change:▼10.74 (-0.38%)In The Wires
-
CHS/Community Health Systems, Inc. Announces Completion of Exchange Offer for Its 8.00% Senior Notes Due 2019 -
InvenSense® Kicks off First Annual Motion Interface Developers Conference -
Tech Data Corporation to Host Annual Meeting of Shareholders on May 30, 2012 -
Medtronic Resolute® Stent Shows Strong Performance in Heart Disease Patients With and Without Diabetes -
Winthrop Realty Trust Announces Resignation of Chief Financial Officer Effective June 15, 2012 -
Hot Topics Recap: London Olympics/Summer Games -
Business Users of Macs Can Now Make Remote Deposits to Wells Fargo with Panini Scanners -
Landauer, Inc. Declares Regular Cash Dividend









